Clinical Trials Logo

Surgery clinical trials

View clinical trials related to Surgery.

Filter by:

NCT ID: NCT05785013 Not yet recruiting - Surgery Clinical Trials

The Impact of Preoperative Supplementation of Zinc

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

1. Pre operative anthropometric assessment including : weight in kg, height/length and BMI 2. Pre operative Zinc supplementation (dose according to the age) for 7 days preoperatively for cases 3. Postoperative data collection

NCT ID: NCT05782686 Recruiting - Breast Cancer Clinical Trials

Impact of Systematic Shaving on Margins

Start date: October 7, 2020
Phase: N/A
Study type: Interventional

The objective of this clinical trial is to demonstrate the reduction of positive margins in the definitive pathology of patients undergoing breast-conserving surgery with the systematic shaving technique compared to conventional surgery, and the reduction of second interventions for margin enlargement.

NCT ID: NCT05782504 Recruiting - Breast Cancer Clinical Trials

Patient-centered Breast Cancer Teleprehabilitation

BC-PREHAB
Start date: January 30, 2023
Phase: N/A
Study type: Interventional

Surgery, the cornerstone of most cancer treatments, is associated with considerable postoperative complications. Adjusting patients' health behavior before surgery may have beneficial effects on postoperative outcomes. Women (n=50) who will undergo breast surgery because of stage I-III breast cancer are eligible. All participants will receive multimodal patient-centered teleprehabilitation comprising of motivational interviewing, education, exercise therapy, and stress management.

NCT ID: NCT05782140 Recruiting - Surgery Clinical Trials

ALgorithms Adapted From Remote Monitoring

ALARM
Start date: February 20, 2023
Phase:
Study type: Observational

Through the aid of remote monitoring and early symptom detection, a patient's response to stress and normalization to their individual baseline can better contribute towards algorithms which are predictive of clinical decline.

NCT ID: NCT05781789 Recruiting - Surgery Clinical Trials

Redesigning Pre-surgery Patient Journeys With Telehealth

Start date: October 3, 2022
Phase:
Study type: Observational

Prior to surgery, patients undergo preanaesthesia assessment to ensure timely optimisation of medical conditions that could adversely impact perioperative outcomes. At the Preadmission Service (PAS) clinic of KK hospital, nurses perform the first triage to identify patients who require outpatient anaesthetic review in advance of surgery. While all elective patients attend the PAS clinic, only 8% are require outpatient anaesthetic review. The majority 92%, can be safely triaged to receive preanaesthesia assessment on the day of surgery. In this project, we propose to investigate the efficacy of a new pre-surgery workflow for elective surgical patients incorporating telehealth. We hypothesize that the redesigned pre-surgery journey incorporating telehealth reduces in-person consultation at the pre-admission clinic by up to 90%. Primary outcome is the proportion of eligible same-day-admission patients assessed via telehealth. Secondary outcomes are: 1. Patient cost and time savings 2. Patient experience of the new model of care 3. Staff experience of the new workflow 4. Incidence of day-of-surgery cancellations

NCT ID: NCT05780125 Not yet recruiting - Surgery Clinical Trials

Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness

EDIPORE
Start date: March 2023
Phase: Phase 2
Study type: Interventional

Fibrinogen concentrate is produced by different manufacturers using different purification technologies. The products available in Italy are three: RIASTAP (CSL Behring), FIBRYGA (Octapharma), and FIBRICLOTTE (LFB). RIASTAP and FIBRYGA are sold in 1-gram vials, and FIBRICLOTTE - in 1.5 grams vials. A recent in vitro study assessed how these products affected the clot firmness measured by the ROTEM FIBTEM maximum clot firmness (MCF) parameter. In vitro conditions, FIBRICLOTTE was verified to be the most efficient in increasing clot firmness. The present study is aimed to assess, in a series of patients undergoing cardiac surgery with cardiopulmonary bypass, the hypothesis that the FIBRICLOTTE fibrinogen is superior to the RIASTAP fibrinogen in increasing the FIBTEM MCF parameter in a clinical model of bleeding (postoperative bleeding after complex cardiac surgery).

NCT ID: NCT05778981 Recruiting - Stroke Clinical Trials

Endothelial Dysfunction and Non-cardiac Surgery

Start date: March 25, 2023
Phase:
Study type: Observational

Endothelial dysfunction is a cardiovascular disease hallmark. After non-cardiac surgery, cardiovascular events correlate with surgical outcomes. Understanding the role of endothelial function in these events is crucial. This research aims to study endothelial function and its association with cardiovascular events.

NCT ID: NCT05776758 Recruiting - Surgery Clinical Trials

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

Start date: March 2023
Phase: Phase 3
Study type: Interventional

This prospective randomized controlled trial (RCT) is designed to provide high level evidence describing the non-inferiority of radical cystectomy (RC) alone versus neoadjuvant chemotherapy (NAC) plus RC on survival outcomes of patients with a diagnostic transurethral resection of bladder tumor (TURBt) of non-metastatic muscle invasive bladder cancer (MIBC) (T2-T4 N0 M0) and non-radiologic or endoscopic residual tumor after a maximal TURBt (cT0). Our hypothesis is that performing NAC in the absence of residual disease, after a maximal TURBt, has no survival benefit over performing an early cystectomy. Since no downstaging could be achieved in patients with no residual tumor into the bladder, the benefits of neoadjuvant chemotherapy in this setting could be not significant and it might turn into unnecessary toxicity and a substantial delay to surgical treatment.

NCT ID: NCT05774743 Not yet recruiting - Surgery Clinical Trials

Pediatric Anesthesia Consent - Visual Aids

Start date: March 31, 2023
Phase: N/A
Study type: Interventional

Informed consent in pediatric anesthesia is obtained from the caregiver by the anesthesiologist prior to surgery. Studies demonstrate that caregivers often do not fully understand or recall the information (risks and benefits) discussed with them during the consent process. The use of visual aids (pictographs etc.) in the consent process has been studied and found beneficial in increasing recall of the discussion about surgery (appendectomy) and for sedation in the emergency department. The investigators developed posters/pamphlets as visual aids with information about general anesthesia and risks involved to help the caregivers understand the process and risks better when their child comes in for an elective procedure. This randomized controlled trial comparing the recall and satisfaction of the standard consent process with and without the use of the visual aids will help evaluate whether the consent process and caregiver understanding can be improved by using these aids.

NCT ID: NCT05774717 Not yet recruiting - Surgery Clinical Trials

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

Start date: April 1, 2023
Phase: Phase 1
Study type: Interventional

This study will be a prospective randomized study to evaluate the effect of tranexamic acid (TXA) use on intraoperative and postoperative outcomes among patients undergoing rhinoplasty by two Facial Plastic surgeons at Vanderbilt. Outcomes will include intra- and post-operative bleeding and postoperative bruising and swelling.